Form 4 for PAYO Payoneer Global Inc.
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0000950103-25-007076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-06-05 | 2025-06-03+ | PAYO | Galit Scott H. | Dir | M - OptEx | $2.86 | +1.09M | 1.71M | +178% | +$3.12M |
| DM | 2025-06-05 | 2025-06-03+ | PAYO | Galit Scott H. | Dir | S - Sale+OE | $6.71 | -1.09M | 1.09M | -50% | -$7.33M |
| DM | 2025-06-05 | 2025-06-03+ | PAYO | Galit Scott H. | Dir | M - OptEx | $0.00 | -1.09M | 115.6K | -90% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-04 | M | A | 106,332 | $3.02 | 1,199,116 | D | — | — | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. |
| 2 | Common | Common Stock | 2025-06-03 | M | A | 115,449 | $2.90 | 1,567,335 | D | — | — | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. |
| 3 | Common | Common Stock | 2025-06-04 | S | D | 479,720 | $6.74 | 1,092,784 | D | — | — | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. (F3) The reported sale price reflects the weighted average sale price for multiple transactions, ranging from $6.625 to $6.775. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 4 | Common | Common Stock | 2025-06-04 | M | A | 373,388 | $2.90 | 1,572,504 | D | — | — | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. |
| 5 | Common | Common Stock | 2025-06-03 | M | A | 359,102 | $2.80 | 1,451,886 | D | — | — | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. |
| 6 | Common | Common Stock | 2025-06-03 | M | A | 138,180 | $2.74 | 1,705,515 | D | — | — | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. |
| 7 | Common | Common Stock | 2025-06-03 | S | D | 612,731 | $6.68 | 1,092,784 | D | — | — | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. (F2) The reported sale price reflects the weighted average sale price for multiple transactions, ranging from $6.57 to $6.76. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
| 8 | Derivative | Stock Options (Right to buy) | 2025-06-04 | M | D | 373,388 | $0.00 | 454,342 | D | $2.90 · — to 2029-02-13 | 373,388 Common Stock | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. (F4) This option is fully vested and exercisable. |
| 9 | Derivative | Stock Options (Right to buy) | 2025-06-03 | M | D | 359,102 | $0.00 | 306,288 | D | $2.80 · — to 2028-02-04 | 359,102 Common Stock | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. (F4) This option is fully vested and exercisable. |
| 10 | Derivative | Stock Options (Right to buy) | 2025-06-04 | M | D | 106,332 | $0.00 | 88,962 | D | $3.02 · — to 2027-02-11 | 106,332 Common Stock | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. (F4) This option is fully vested and exercisable. |
| 11 | Derivative | Stock Options (Right to buy) | 2025-06-03 | M | D | 115,449 | $0.00 | 827,730 | D | $2.90 · — to 2029-02-13 | 115,449 Common Stock | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. (F4) This option is fully vested and exercisable. |
| 12 | Derivative | Stock Options (Right to buy) | 2025-06-03 | M | D | 138,180 | $0.00 | 115,620 | D | $2.74 · — to 2030-03-19 | 138,180 Common Stock | (F1) The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2025. (F4) This option is fully vested and exercisable. |